| Serial Number | 90557587 |
| Word Mark | IXAKA |
| Filing Date | Wednesday, March 3, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 7, 2022 |
| Goods and Services | Production of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, production, and manufacture for others; Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of biopharmaceuticals by pharmaceutical compounders |
| Goods and Services | Chemical, analytical and diagnostic reagents for in vivo use for medical purposes; Pharmaceutical preparations for use in the prevention and treatment of cardiovascular diseases, cancer and genetic disorders; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders |
| Goods and Services | Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific or research use |
| Goods and Services | Drug delivery devices sold empty, namely, syringes, bags, infusion and injection sets; structural parts, fittings and accessories for all the aforesaid goods |
| Goods and Services | Scientific, medical and industrial research and development services in the field of cardiovascular diseases, cancer, genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; clinical research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; laboratory research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; research and development of new drugs and clinical products; materials analyzing; chemical analysis; scientific laboratory services; laboratory testing services for scientific research purposes; medical laboratory services; information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the Internet; Research and development services for pharmaceuticals and for the treatment of diseases and injuries; Genetic engineering services for scientific research purposes; Genetic research being scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals and gene therapy; medical and scientific research, namely, conducting clinical trials for others; Research and development of pharmaceutical preparations |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 2, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 2, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 2, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 2, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 2, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ixaka Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London SW1X0BD GB |
| Party Name | Ixaka Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London SW1X0BD GB |
| Event Date | Event Description |
| Monday, March 4, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 4, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, August 4, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 2, 2023 | SOU EXTENSION 2 GRANTED |
| Wednesday, August 2, 2023 | SOU EXTENSION 2 FILED |
| Wednesday, August 2, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 14, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 12, 2022 | SOU EXTENSION 1 GRANTED |
| Monday, December 12, 2022 | SOU EXTENSION 1 FILED |
| Monday, December 12, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 2, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 7, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 7, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 18, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, April 30, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 27, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 18, 2022 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, April 18, 2022 | PRIORITY ACTION E-MAILED |
| Monday, April 18, 2022 | PRIORITY ACTION WRITTEN |
| Monday, March 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 28, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, March 26, 2022 | ASSIGNED TO LIE |
| Wednesday, March 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, September 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, September 26, 2021 | NON-FINAL ACTION E-MAILED |
| Sunday, September 26, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, September 25, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, June 2, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 6, 2021 | NEW APPLICATION ENTERED |